CONTEXTVISION AB (CONTX.OL) Fundamental Analysis & Valuation

OSL:CONTX • SE0014731154

Current stock price

3.3 NOK
-0.05 (-1.49%)
Last:

This CONTX.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CONTX.OL Profitability Analysis

1.1 Basic Checks

  • In the past year CONTX was profitable.
  • CONTX had a positive operating cash flow in the past year.
  • Of the past 5 years CONTX 4 years were profitable.
  • CONTX had a positive operating cash flow in each of the past 5 years.
CONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFCONTX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

1.2 Ratios

  • The Return On Assets of CONTX (0.61%) is comparable to the rest of the industry.
  • CONTX has a Return On Equity of 0.83%. This is comparable to the rest of the industry: CONTX outperforms 41.67% of its industry peers.
  • With a Return On Invested Capital value of 0.30%, CONTX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • CONTX had an Average Return On Invested Capital over the past 3 years of 20.44%. This is significantly above the industry average of 7.44%.
  • The 3 year average ROIC (20.44%) for CONTX is well above the current ROIC(0.30%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROIC 0.3%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
CONTX.OL Yearly ROA, ROE, ROICCONTX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.69%, CONTX is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CONTX has declined.
  • With a Operating Margin value of 0.36%, CONTX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
  • CONTX's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 97.37%, CONTX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
Industry RankSector Rank
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
CONTX.OL Yearly Profit, Operating, Gross MarginsCONTX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

5

2. CONTX.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
  • The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
  • Compared to 1 year ago, CONTX has a worse debt to assets ratio.
CONTX.OL Yearly Shares OutstandingCONTX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CONTX.OL Yearly Total Debt VS Total AssetsCONTX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • CONTX has a debt to FCF ratio of 62.32. This is a negative value and a sign of low solvency as CONTX would need 62.32 years to pay back of all of its debts.
  • CONTX has a Debt to FCF ratio of 62.32. This is comparable to the rest of the industry: CONTX outperforms 41.67% of its industry peers.
  • CONTX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • CONTX has a Debt to Equity ratio of 0.10. This is comparable to the rest of the industry: CONTX outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Altman-Z N/A
ROIC/WACC0.04
WACC7.01%
CONTX.OL Yearly LT Debt VS Equity VS FCFCONTX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • CONTX has a Current Ratio of 4.28. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.28, CONTX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • CONTX has a Quick Ratio of 4.23. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
  • CONTX's Quick ratio of 4.23 is amongst the best of the industry. CONTX outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.23
CONTX.OL Yearly Current Assets VS Current LiabilitesCONTX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. CONTX.OL Growth Analysis

3.1 Past

  • CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.77%.
  • Measured over the past years, CONTX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -41.36% on average per year.
  • Looking at the last year, CONTX shows a very negative growth in Revenue. The Revenue has decreased by -15.61% in the last year.
  • CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.08% yearly.
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%

3.2 Future

  • CONTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 188.45% yearly.
  • Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CONTX.OL Yearly Revenue VS EstimatesCONTX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M
CONTX.OL Yearly EPS VS EstimatesCONTX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4 0.5

3

4. CONTX.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 330.00, the valuation of CONTX can be described as expensive.
  • CONTX's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.95, CONTX is valued quite expensively.
  • With a Price/Forward Earnings ratio of 31.44, CONTX can be considered very expensive at the moment.
  • CONTX's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. CONTX is around the same levels.
Industry RankSector Rank
PE 330
Fwd PE 31.44
CONTX.OL Price Earnings VS Forward Price EarningsCONTX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, CONTX is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 1240.24
EV/EBITDA N/A
CONTX.OL Per share dataCONTX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

  • CONTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CONTX may justify a higher PE ratio.
  • CONTX's earnings are expected to grow with 188.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y188.45%

6

5. CONTX.OL Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
  • CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.34. CONTX pays more dividend than 83.33% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CONTX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DP0%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
CONTX.OL Yearly Income VS Free CF VS DividendCONTX.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

CONTX.OL Fundamentals: All Metrics, Ratios and Statistics

CONTEXTVISION AB

OSL:CONTX (4/20/2026, 4:19:56 PM)

3.3

-0.05 (-1.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-19
Earnings (Next)05-08
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners23.66%
Ins Owner ChangeN/A
Market Cap255.32M
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Analysts40
Price Target3.37 (2.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.5%
PT rev (3m)-17.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE 330
Fwd PE 31.44
P/S 2.27
P/FCF 1240.24
P/OCF 56.41
P/B 2.72
P/tB 2.79
EV/EBITDA N/A
EPS(TTM)0.01
EY0.3%
EPS(NY)0.1
Fwd EY3.18%
FCF(TTM)0
FCFY0.08%
OCF(TTM)0.06
OCFY1.77%
SpS1.45
BVpS1.21
TBVpS1.18
PEG (NY)0.3
PEG (5Y)N/A
Graham Number0.522626 (-84.16%)
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 0.83%
ROCE 0.39%
ROIC 0.3%
ROICexc 0.96%
ROICexgc 1.03%
OM 0.36%
PM (TTM) 0.69%
GM 97.37%
FCFM 0.18%
ROA(3y)16.48%
ROA(5y)14.4%
ROE(3y)23.03%
ROE(5y)18.42%
ROIC(3y)20.44%
ROIC(5y)37.45%
ROICexc(3y)77.73%
ROICexc(5y)111.49%
ROICexgc(3y)103.93%
ROICexgc(5y)184.88%
ROCE(3y)26.61%
ROCE(5y)48.75%
ROICexgc growth 3Y-81.88%
ROICexgc growth 5Y-66.49%
ROICexc growth 3Y-79.52%
ROICexc growth 5Y-59.81%
OM growth 3Y-77.87%
OM growth 5Y-62.43%
PM growth 3Y-69.2%
PM growth 5Y-43.82%
GM growth 3Y-1.24%
GM growth 5Y-0.07%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 62.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 3.84%
Interest Coverage 0.99
Cash Conversion N/A
Profit Quality 26.51%
Current Ratio 4.28
Quick Ratio 4.23
Altman-Z N/A
F-Score5
WACC7.01%
ROIC/WACC0.04
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.73%
Cap/Sales(5y)4.01%
Profit Quality(3y)87.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.77%
EPS 3Y-69.6%
EPS 5Y-41.36%
EPS Q2Q%-42.87%
EPS Next Y1100%
EPS Next 2Y324.26%
EPS Next 3Y188.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.61%
Revenue growth 3Y-2.18%
Revenue growth 5Y3.08%
Sales Q2Q%-7.27%
Revenue Next Year7.55%
Revenue Next 2Y4.61%
Revenue Next 3Y3.64%
Revenue Next 5Y2.7%
EBIT growth 1Y-98.68%
EBIT growth 3Y-78.36%
EBIT growth 5Y-61.27%
EBIT Next Year2775%
EBIT Next 3Y208.99%
EBIT Next 5YN/A
FCF growth 1Y-99.31%
FCF growth 3Y-78.75%
FCF growth 5Y-57.02%
OCF growth 1Y-86.52%
OCF growth 3Y-44.44%
OCF growth 5Y-27.59%

CONTEXTVISION AB / CONTX.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.


What is the valuation status for CONTX stock?

ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.


Can you provide the profitability details for CONTEXTVISION AB?

CONTEXTVISION AB (CONTX.OL) has a profitability rating of 6 / 10.


What is the valuation of CONTEXTVISION AB based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CONTEXTVISION AB (CONTX.OL) is 330 and the Price/Book (PB) ratio is 2.72.


What is the earnings growth outlook for CONTEXTVISION AB?

The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to grow by 1100% in the next year.